News

News

No. Title Written by Date Read
14 Enter into CDMO Agreement with Samsung Biologics /Eyes of CEO/Hankyung TV Admin 20.08.13 93
13 STCube signs additional development and manufacturing agreement with Samsung Biologics Admin 20.07.12 102
12 STCube Presents Data on Its Proprietary PD-1 Antibody at AACR Admin 20.06.23 159
11 STCube Applies for a U.S. Patent on the COVID-19 Anti-viral Treatment Using 'STT-003' Admin 20.03.30 87
10 STCube Initiates a CRO Contract for Development of COVID-19 Treatment Using ‘STT-003’ Admin 20.03.23 87
9 STCube Publishes Research Paper on Its Antibody to Immune-checkpoint Inhibitor PD-1 in Cancer Research, an International Academic Journal Admin 20.03.12 98
8 STCube and Samsung Biologics Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug Admin 20.03.03 97
7 STCube Obtains EU Patent for Screening Method for Cancer Immunotherapy Candidates Using Radiation Admin 19.11.28 3,346
6 STCube Attracts Investment of 42 Billion Won, “Accelerating Development of Anti-cancer Immunotherapies Admin 18.04.25 86
5 A Road to Conquering Cancer — Successful Development of Antibody Drug as Potential Cure for Difficult-to-Treat Cancer Admin 18.02.13 87